DNAPrint Genomics Inc
OTC:DNAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DNAPrint Genomics Inc
OTC:DNAG
|
US |
|
Envipco Holding NV
F:E1P0
|
NL |
|
E
|
EDP SA
F:EDP
|
PT |
|
N
|
NH Special Purpose Acquisition 30 Co
KOSDAQ:466910
|
KR |
|
I
|
IES Holdings Inc
F:45T
|
US |
|
Tandem Group PLC
LSE:TND
|
UK |
|
Syensqo NV
F:2NF
|
BE |
|
Talga Group Ltd
OTC:TLGRF
|
AU |
|
Advanced Container Technologies Inc
OTC:ACTX
|
US |
|
E
|
Essity AB (publ)
SWB:ESW
|
SE |
|
W
|
W T K Holdings Bhd
KLSE:WTK
|
MY |
|
Diablo Resources Ltd
OTC:DBORF
|
AU |
|
Tracsis PLC
F:4T2
|
UK |
|
T
|
Telefonaktiebolaget LM Ericsson
XMUN:ERCG
|
SE |
|
T
|
TDK Corp
OTC:TTDKF
|
JP |
|
BSA Ltd
ASX:BSA
|
AU |
|
A
|
Achieve Life Sciences Inc
F:SP4P
|
US |
|
M
|
Metair Investments Ltd
F:M4HA
|
ZA |
|
M
|
MegaMD Co Ltd
KOSDAQ:133750
|
KR |
|
S
|
Sensirion Holding AG
SIX:SENS
|
CH |
|
H
|
Hanjoo Light Metal Co Ltd
KOSDAQ:198940
|
KR |
|
Progressive Planet Solutions Inc
F:ARB3
|
CA |
|
Medipal Holdings Corp
TSE:7459
|
JP |
|
Denison Mines Corp
TSX:DML
|
CA |
Bankruptcy Probability
DNAPrint Genomics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DNAPrint Genomics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
D
|
DNAPrint Genomics Inc
OTC:DNAG
|
644.6 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
135.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DNAPrint Genomics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DNAPrint Genomics Inc has total debt of 5.2m USD. This includes both short-term (4.9m USD) and long-term (260k USD) debt.
You can find a full breakdown on its Balance Sheet.